15059 Baricitinib, an oral reversible Janus kinase 1 and 2...

Journal of the American Academy of Dermatology 2020 / 12 Vol. 83; Iss. 6

15059 Baricitinib, an oral reversible Janus kinase 1 and 2 inhibitor, for atopic dermatitis: Head and neck response across two phase 3 studies

Simpson, Eric, Bissonnette, Robert, Nunes, Fabio P., Jose Rueda, Maria, Paul, Carle
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
83
Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2020.06.200
Date:
December, 2020
File:
PDF, 260 KB
2020
Conversion to is in progress
Conversion to is failed